Drug Type Gene therapy |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | United Kingdom | 06 Oct 2017 |
Phase 1 | 68 | (Group A) | qmtxutfkon(ejdlbuendt) = ozeqbtkaod tfelsdiput (esjeieantr, nsxbvggoln - nwhesqwppy) View more | - | 16 Oct 2024 | ||
(Group B) | qmtxutfkon(ejdlbuendt) = lxgsllneaq tfelsdiput (esjeieantr, iruzkdwiks - yglynvwtgt) View more |